PEAK6 Group’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

PEAK6 Group’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,974	Closed	-$19K	–	5266
2016 Q1	$19K	Buy	+5,974	New	+$20K	﹤0.01%	4125
2015 Q4	–	Sell	-3,290	Closed	-$15.6K	–	5909
2015 Q3	$15K	Sell	3,290 -34,581	-91%	-$223K	﹤0.01%	4927
2015 Q2	$271K	Sell	37,871 -47,425	-56%	-$357K	﹤0.01%	3430
2015 Q1	$722K	Buy	85,296 +9,991	+13%	+$85.1K	0.01%	2211
2014 Q4	$701K	Buy	75,305 +58,559	+350%	+$509K	0.01%	2271
2014 Q3	$139K	Buy	+16,746	New	+$155K	﹤0.01%	3581
2014 Q2	–	Sell	-36,278	Closed	-$372K	–	5768
2014 Q1	$460K	Buy	+36,278	New	+$469K	﹤0.01%	2628

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PEAK6 Group's DSCI Position: Q2 2016 in Review

PEAK6 Group sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2016, closing a stake of 5,974 shares — an estimated $19K sold.

PEAK6 Group first reported a position in DSCI in Q1 2014 and held it in 7 quarters. The position peaked at $722K in Q1 2015. 53 funds tracked by Wall St. Rank hold DSCI as of Q2 2016.

PEAK6 Group reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2016 after selling out during the quarter.
PEAK6 Group sold 5,974 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2016, an estimated $19K.
PEAK6 Group first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 7 quarters.
PEAK6 Group's Derma Sciences, Inc. Common Stock (DE) position peaked at $722K in Q1 2015.
53 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.